{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:45:11Z","timestamp":1790711111869,"version":"4.1.0"},"reference-count":55,"publisher":"American Diabetes Association","issue":"7","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,7,1]]},"abstract":"<jats:p>Type 2 diabetes is characterized by loss of \u03b2-cell mass and concomitant deposition of amyloid derived from islet amyloid polypeptide (IAPP). Previously we have shown that expression of human IAPP (huIAPP) in islets of transgenic mice results in either a rapid onset of hyperglycemia in mice homozygous for the huIAPP transgene on a lean background (FVB\/N) or a gradual hyperglycemia in mice hemizygous for the huIAPP transgene on an obese background (Avy\/A). In both strains, only the males routinely develop diabetes. To investigate this sexual dimorphism, we treated young prediabetic Avy\/A mice transgenic for huIAPP (huIAPP-Avy) with 17\u03b2-estradiol (E2). The treatment completely blocked the progression to hyperglycemia but also prevented the associated weight gain in these mice. Immunohistochemistry of pancreatic sections demonstrated normal islet morphology with no apparent deposition of islet amyloid. E2 treatment of 1-year-old huIAPP-Avy diabetic males rapidly reverses obesity and hyperglycemia. To determine the effects of E2 in a nonobese model, we also treated prediabetic, ad libitum\u2013fed and pair-fed Lean-huIAPP transgenic males. E2 completely blocked the progression to hyperglycemia with no significant effect on body weight. Pancreatic insulin content and plasma insulin concentration of Lean-huIAPP transgenic mice increased in a dose-dependent manner. We demonstrated the presence of estrogen receptor (ER)-\u03b1 mRNA in mouse and human islets. By also confirming the presence of ER-\u03b1 protein in islets, we discovered a novel 58-kDa ER-\u03b1 isoform in mice and a 52-kDa isoform in humans, in the absence of the classic 67-kDa protein found in most tissues of both species. The demonstrated presence of ER-\u03b1 in mouse and human islets is consistent with a direct effect on islet function. We conclude that exogenous E2 administered to male mice may block human IAPP-mediated \u03b2-cell loss both by direct action on \u03b2-cells and by decreasing insulin demand through inhibition of weight gain or increasing insulin action.<\/jats:p>","DOI":"10.2337\/diabetes.51.7.2158","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"2158-2169","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":62,"title":["Estrogen Can Prevent or Reverse Obesity and Diabetes in Mice Expressing Human Islet Amyloid Polypeptide"],"prefix":"10.2337","volume":"51","author":[{"given":"John G.","family":"Geisler","sequence":"first","affiliation":[{"name":"Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Zawalich","sequence":"additional","affiliation":[{"name":"Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Zawalich","sequence":"additional","affiliation":[{"name":"Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.T.","family":"Lakey","sequence":"additional","affiliation":[{"name":"University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Stukenbrok","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Milici","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C.","family":"Soeller","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031222552759500_R1","doi-asserted-by":"crossref","unstructured":"Kahn CR: Banting Lecture: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes\u200843:1066\u20131084, 1994","DOI":"10.2337\/diab.43.8.1066"},{"key":"2022031222552759500_R2","doi-asserted-by":"crossref","unstructured":"Polonsky KS, Sturis J, Bell GI: Seminars in medicine of the Beth Israel Hospital, Boston: non-insulin-dependent diabetes mellitus\u2014a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med\u2008334:777\u2013783, 1996","DOI":"10.1056\/NEJM199603213341207"},{"key":"2022031222552759500_R3","doi-asserted-by":"crossref","unstructured":"Clark A, Charge SB, Badman MK, de Koning EJ: Islet amyloid in type 2 (non-insulin-dependent) diabetes. APMIS\u2008104:12\u201318, 1996","DOI":"10.1111\/j.1699-0463.1996.tb00680.x"},{"key":"2022031222552759500_R4","doi-asserted-by":"crossref","unstructured":"Kahn SE, Andrikopoulos S, Verchere CB: Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes\u200848:241\u2013253, 1999","DOI":"10.2337\/diabetes.48.2.241"},{"key":"2022031222552759500_R5","doi-asserted-by":"crossref","unstructured":"Hoppener JW, Verbeek JS, de Koning EJ, Oosterwijk C, van Hulst KL, Visser-Vernooy HJ, Hofhuis FM, van Gaalen S, Berends MJ, Hackeng WH, et al.: Chronic overproduction of islet amyloid polypeptide\/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia\u200836:1258\u20131265, 1993","DOI":"10.1007\/BF00400803"},{"key":"2022031222552759500_R6","doi-asserted-by":"crossref","unstructured":"Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC: Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A\u200893:7283\u20137288, 1996","DOI":"10.1073\/pnas.93.14.7283"},{"key":"2022031222552759500_R7","unstructured":"Janson J, Butler P, Soeller W: High islet amyloid polypeptide secretion results in transient hyperglycemia without beta-cell death (Abstract). Diabetes\u200847 (Suppl. 1):A30, 1998"},{"key":"2022031222552759500_R8","doi-asserted-by":"crossref","unstructured":"Soeller WC, Janson J, Hart SE, Parker JC, Carty MD, Stevenson RW, Kreutter DK, Butler PC: Islet amyloid-associated diabetes in obese A(vy)\/a mice expressing human islet amyloid polypeptide. Diabetes\u200847:743\u2013750, 1998","DOI":"10.2337\/diabetes.47.5.743"},{"key":"2022031222552759500_R9","doi-asserted-by":"crossref","unstructured":"Leiter EH, Kintner J, Flurkey K, Beamer WG, Naggert JK: Physiologic and endocrinologic characterization of male sex-biased diabetes in C57BLKS\/J mice congenic for the fat mutation at the carboxypeptidase E locus. Endocrine\u200810:57\u201366, 1999","DOI":"10.1385\/ENDO:10:1:57"},{"key":"2022031222552759500_R10","doi-asserted-by":"crossref","unstructured":"Leiter EH, Chapman HD: Obesity-induced diabetes (diabesity) in C57BL\/KsJ mice produces aberrant trans-regulation of sex steroid sulfotransferase genes. J Clin Invest\u200893:2007\u20132013, 1994","DOI":"10.1172\/JCI117194"},{"key":"2022031222552759500_R11","doi-asserted-by":"crossref","unstructured":"Bultman SJ, Michaud EJ, Woychik RP: Molecular characterization of the mouse agouti locus. Cell\u200871:1195\u20131204, 1992","DOI":"10.1016\/S0092-8674(05)80067-4"},{"key":"2022031222552759500_R12","doi-asserted-by":"crossref","unstructured":"Klebig ML, Wilkinson JE, Geisler JG, Woychik RP: Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci U S A\u200892:4728\u20134732, 1995","DOI":"10.1073\/pnas.92.11.4728"},{"key":"2022031222552759500_R13","doi-asserted-by":"crossref","unstructured":"Klinge CM: Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res\u200829:2905\u20132919, 2001","DOI":"10.1093\/nar\/29.14.2905"},{"key":"2022031222552759500_R14","doi-asserted-by":"crossref","unstructured":"Leiter EH, Chapman HD, Falany CN: Synergism of obesity genes with hepatic steroid sulfotransferases to mediate diabetes in mice. Diabetes\u200840:1360\u20131363, 1991","DOI":"10.2337\/diabetes.40.10.1360"},{"key":"2022031222552759500_R15","doi-asserted-by":"crossref","unstructured":"Falany JL, Krasnykh V, Mikheeva G, Falany CN: Isolation and expression of an isoform of rat estrogen sulfotransferase. J Steroid Biochem Mol Biol\u200852:35\u201344, 1995","DOI":"10.1016\/0960-0760(94)00147-E"},{"key":"2022031222552759500_R16","doi-asserted-by":"crossref","unstructured":"Qian YM, Sun XJ, Tong MH, Li XP, Richa J, Song WC: Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation. Endocrinology\u2008142:5342\u20135350, 2001","DOI":"10.1210\/endo.142.12.8540"},{"key":"2022031222552759500_R17","doi-asserted-by":"crossref","unstructured":"Krakower GR, Meier DA, Kissebah AH: Female sex hormones, perinatal, and peripubertal androgenization on hepatocyte insulin dynamics in rats. Am J Physiol\u2008264:E342\u2013E347, 1993","DOI":"10.1152\/ajpendo.1993.264.3.E342"},{"key":"2022031222552759500_R18","doi-asserted-by":"crossref","unstructured":"Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER: Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A\u200897:12735\u201312740, 2000","DOI":"10.1073\/pnas.97.23.12735"},{"key":"2022031222552759500_R19","doi-asserted-by":"crossref","unstructured":"Nemoto Y, Toda K, Ono M, Fujikawa-Adachi K, Saibara T, Onishi S, Enzan H, Okada T, Shizuta Y: Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest\u2008105:1819\u20131825, 2000","DOI":"10.1172\/JCI9575"},{"key":"2022031222552759500_R20","doi-asserted-by":"crossref","unstructured":"Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS: Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A\u200897:12729\u201312734, 2000","DOI":"10.1073\/pnas.97.23.12729"},{"key":"2022031222552759500_R21","doi-asserted-by":"crossref","unstructured":"Saibara T, Onishi S, Ogawa Y, Yoshida S, Enzan H: Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis. Lancet\u2008353:1802, 1999","DOI":"10.1016\/S0140-6736(05)75907-9"},{"key":"2022031222552759500_R22","doi-asserted-by":"crossref","unstructured":"Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med\u2008331:1056\u20131061, 1994","DOI":"10.1056\/NEJM199410203311604"},{"key":"2022031222552759500_R23","doi-asserted-by":"crossref","unstructured":"Albano JD, Ekins RP, Maritz G, Turner RC: A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh)\u200870:487\u2013509, 1972","DOI":"10.1530\/acta.0.0700487"},{"key":"2022031222552759500_R24","doi-asserted-by":"crossref","unstructured":"Geary N, Asarian L, Korach KS, Pfaff DW, Ogawa S: Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology\u2008142:4751\u20134757, 2001","DOI":"10.1210\/endo.142.11.8504"},{"key":"2022031222552759500_R25","doi-asserted-by":"crossref","unstructured":"Couse JF, Korach KS: Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev\u200820:358\u2013417, 1999","DOI":"10.1210\/edrv.20.3.0370"},{"key":"2022031222552759500_R26","doi-asserted-by":"crossref","unstructured":"McCormack JT, Greenwald GS: Progesterone and oestradiol-17beta concentrations in the peripheral plasma during pregnancy in the mouse. J Endocrinol\u200862:101\u2013107, 1974","DOI":"10.1677\/joe.0.0620101"},{"key":"2022031222552759500_R27","doi-asserted-by":"crossref","unstructured":"Couce M, O\u2019Brien TD, Moran A, Roche PC, Butler PC: Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab\u200881:1267\u20131272, 1996","DOI":"10.1210\/jcem.81.3.8772610"},{"key":"2022031222552759500_R28","doi-asserted-by":"crossref","unstructured":"Kahn SE, Andrikopoulos S, Verchere CB, Wang F, Hull RL, Vidal J: Oophorectomy promotes islet amyloid formation in a transgenic mouse model of type II diabetes. Diabetologia\u200843:1309\u20131312, 2000","DOI":"10.1007\/s001250051527"},{"key":"2022031222552759500_R29","doi-asserted-by":"crossref","unstructured":"Wade GN: Gonadal hormones and behavioral regulation of body weight. Physiol Behav\u20088:523\u2013534, 1972","DOI":"10.1016\/0031-9384(72)90340-X"},{"key":"2022031222552759500_R30","doi-asserted-by":"crossref","unstructured":"Ogawa Y, Murata Y, Nishioka A, Inomata T, Yoshida S: Tamoxifen-induced fatty liver in patients with breast cancer. Lancet\u2008351:725, 1998","DOI":"10.1016\/S0140-6736(05)78493-2"},{"key":"2022031222552759500_R31","doi-asserted-by":"crossref","unstructured":"Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ, Kelly DP: A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice. J Clin Invest\u2008102:1083\u20131091, 1998","DOI":"10.1172\/JCI3949"},{"key":"2022031222552759500_R32","unstructured":"Heine PA, Jensen DR, Taylor JA, Lubahn DB, Eckel RH, Cooke PS: Estrogen receptor alpha (ER) regulates the effect of estrogen on metabolic rate (MR) (Abstract). The Endocrine Society 83rd Annual Meeting Bethesda, MD, Enodcrine Society, 2001, p.472"},{"key":"2022031222552759500_R33","doi-asserted-by":"crossref","unstructured":"Demerath EW, Towne B, Wisemandle W, Blangero J, Chumlea WC, Siervogel RM: Serum leptin concentration, body composition, and gonadal hormones during puberty. Int J Obes Relat Metab Disord\u200823:678\u2013685, 1999","DOI":"10.1038\/sj.ijo.0800902"},{"key":"2022031222552759500_R34","doi-asserted-by":"crossref","unstructured":"Shimizu H, Shimomura Y, Nakanishi Y, Futawatari T, Ohtani K, Sato N, Mori M: Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol\u2008154:285\u2013292, 1997","DOI":"10.1677\/joe.0.1540285"},{"key":"2022031222552759500_R35","doi-asserted-by":"crossref","unstructured":"Machinal F, Dieudonne MN, Leneveu MC, Pecquery R, Giudicelli Y: In vivo and in vitro ob gene expression and leptin secretion in rat adipocytes: evidence for a regional specific regulation by sex steroid hormones. Endocrinology\u2008140:1567\u20131574, 1999","DOI":"10.1210\/endo.140.4.6617"},{"key":"2022031222552759500_R36","doi-asserted-by":"crossref","unstructured":"O\u2019Neil JS, Burow ME, Green AE, McLachlan JA, Henson MC: Effects of estrogen on leptin gene promoter activation in MCF-7 breast cancer and JEG-3 choriocarcinoma cells: selective regulation via estrogen receptors alpha and beta. Mol Cell Endocrinol\u2008176:67\u201375, 2001","DOI":"10.1016\/S0303-7207(01)00473-7"},{"key":"2022031222552759500_R37","doi-asserted-by":"crossref","unstructured":"Leiter EH, Beamer WG, Coleman DL, Longcope C: Androgenic and estrogenic metabolites in serum of mice fed dehyroepiandrosterone: relationship to antihyperglycemic effects. Metabolism\u200836:863\u2013869, 1987","DOI":"10.1016\/0026-0495(87)90095-3"},{"key":"2022031222552759500_R38","doi-asserted-by":"crossref","unstructured":"Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science\u2008269:543\u2013546, 1995","DOI":"10.1126\/science.7624777"},{"key":"2022031222552759500_R39","doi-asserted-by":"crossref","unstructured":"Horvath G, Leser G, Helou K, Henriksson M: Function of the exon 7 deletion variant estrogen receptor \u03b1 protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice. Gynecol Oncol\u200884:271\u2013279, 2002","DOI":"10.1006\/gyno.2001.6509"},{"key":"2022031222552759500_R40","doi-asserted-by":"crossref","unstructured":"Kos M, O\u2019Brien S, Flouriot G, Gannon F: Tissue-specific expression of multiple mRNA variants of the mouse estrogen receptor alpha gene. FEBS Lett\u2008477:15\u201320, 2000","DOI":"10.1016\/S0014-5793(00)01750-6"},{"key":"2022031222552759500_R41","doi-asserted-by":"crossref","unstructured":"Denger S, Reid G, Kos M, Flouriot G, Parsch D, Brand H, Korach KS, Sonntag-Buck V, Gannon F: ER\u03b1 gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol Endocrinol\u200815:2064\u20132077, 2001","DOI":"10.1210\/mend.15.12.0741"},{"key":"2022031222552759500_R42","doi-asserted-by":"crossref","unstructured":"Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS: Tissue distribution and quantitative analysis of estrogen receptor-alpha (ER\u03b1) and estrogen receptor-beta (ER\u03b2) messenger ribonucleic acid in the wild-type and ER\u03b1-knockout mouse. Endocrinology\u2008138:4613\u20134621, 1997","DOI":"10.1210\/endo.138.11.5496"},{"key":"2022031222552759500_R43","doi-asserted-by":"crossref","unstructured":"White R, Lees JA, Needham M, Ham J, Parker M: Structural organization and expression of the mouse estrogen receptor. Mol Endocrinol\u20081:735\u2013744, 1987","DOI":"10.1210\/mend-1-10-735"},{"key":"2022031222552759500_R44","doi-asserted-by":"crossref","unstructured":"Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K: Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab\u200880:3689\u20133698, 1995","DOI":"10.1210\/jcem.80.12.8530621"},{"key":"2022031222552759500_R45","unstructured":"Berne RM, Levy MN: Physiology. St. Louis, MO, Mosby Publishing, 1998"},{"key":"2022031222552759500_R46","doi-asserted-by":"crossref","unstructured":"Pincus G, Joslin EP, White P: Age-incidence relations in diabetes mellitus. Am J Med Sci\u2008188:116\u2013121, 1934","DOI":"10.1097\/00000441-193407000-00015"},{"key":"2022031222552759500_R47","doi-asserted-by":"crossref","unstructured":"King H, Rewers M: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care\u200816:157\u2013177, 1993","DOI":"10.2337\/diacare.16.1.157"},{"key":"2022031222552759500_R48","doi-asserted-by":"crossref","unstructured":"Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest\u2008106:171\u2013176, 2000","DOI":"10.1172\/JCI10583"},{"key":"2022031222552759500_R49","doi-asserted-by":"crossref","unstructured":"Westermark P: Quantitative studies on amyloid in the islets of Langerhans. Ups J Med Sci\u200877:91\u201394, 1972","DOI":"10.1517\/03009734000000014"},{"key":"2022031222552759500_R50","doi-asserted-by":"crossref","unstructured":"Opie EL: The relation of diabetes mellitus to lesions of the pancreas: hyaline degeneration of the islands of Langerhans. J Exp Med\u20085:527\u2013540, 1901","DOI":"10.1084\/jem.5.5.527"},{"key":"2022031222552759500_R51","doi-asserted-by":"crossref","unstructured":"Hoppener JW, Ahren B, Lips CJ: Islet amyloid and type 2 diabetes mellitus. N Engl J Med\u2008343:411\u2013419, 2000","DOI":"10.1056\/NEJM200008103430607"},{"key":"2022031222552759500_R52","doi-asserted-by":"crossref","unstructured":"McGarry JD: What if Minkowski had been ageusic? An alternative angle on diabetes. Science\u2008258:766\u2013770, 1992","DOI":"10.1126\/science.1439783"},{"key":"2022031222552759500_R53","doi-asserted-by":"crossref","unstructured":"Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, Lowell BB: Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell\u2008105:745\u2013755, 2001","DOI":"10.1016\/S0092-8674(01)00378-6"},{"key":"2022031222552759500_R54","doi-asserted-by":"crossref","unstructured":"Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI: Mechanism of insulin resistance in A-ZIP\/F-1 fatless mice. J Biol Chem\u2008275:8456\u20138460, 2000","DOI":"10.1074\/jbc.275.12.8456"},{"key":"2022031222552759500_R55","doi-asserted-by":"crossref","unstructured":"Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, Lutz EP, Kako Y, Velez-Carrasco W, Goldberg IJ, Breslow JL, Shulman GI: Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A\u200898:7522\u20137527, 2001","DOI":"10.1073\/pnas.121164498"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/51\/7\/2158\/340788\/db0702002158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/51\/7\/2158\/340788\/db0702002158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:14:57Z","timestamp":1667405697000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/51\/7\/2158\/34507\/Estrogen-Can-Prevent-or-Reverse-Obesity-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.51.7.2158","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,1]]}}}